BML reports 5.225M shares (7.8%) in enGene
enGene Holdings Inc. ownership disclosure: BML Investment Partners, L.P. reports beneficial ownership of 5,225,000 common shares, representing 7.8% of the class as shown on 05/08/2026.
Rhea-AI Filing Summary
enGene Holdings Inc. ownership disclosure: BML Investment Partners, L.P. reports beneficial ownership of 5,225,000 common shares, representing 7.8% of the class as shown on 05/08/2026. The filing states shared voting and dispositive power over these shares through BML Capital Management, LLC and Braden M. Leonard.
Positive
- None.
Negative
- None.
Insights
Large passive stake disclosed by an investment partnership; holdings reported as shared power.
BML Investment Partners, L.P. reports beneficial ownership of 5,225,000 common shares (CUSIP 29286M105), equal to 7.8% of outstanding shares as of 05/08/2026. The filing attributes voting and dispositive authority to shared-control entities.
Future disclosures or amendments would show any changes; the filing includes a standard disclaimer that the reporting persons do not form a statutory group under Rule 13d-5(b)(1). Cash-flow treatment and intended disposition strategies are not described in the excerpt.
Key Figures
Key Terms
Schedule 13G regulatory
Beneficial ownership financial
CUSIP regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does BML Investment Partners hold in enGene (ENGN)?
Does the Schedule 13G state whether BML is part of a group?
What identifier and filing date appear in the disclosure?
AI-generated analysis. How Rhea-AI works. Not financial advice.